相似文献
1
[Screening for uterine cervical cancer in Belgium in 2003].
Rev Med Liege. 2003 May;58(5):316-8.
2
The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):536-9.
3
Adding a test for human papillomavirus DNA to cervical-cancer screening.
N Engl J Med. 2003 Feb 6;348(6):489-90. doi: 10.1056/NEJMp020178.
4
Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):321-30. doi: 10.1158/1055-9965.EPI-08-0510.
5
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
BJOG. 2004 Aug;111(8):842-8. doi: 10.1111/j.1471-0528.2004.00210.x.
6
Human papillomavirus testing for primary cervical cancer screening.
Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599.
7
[How technology and vaccination have changed the Pap test].
Pathologica. 1999 Feb;91(1):36-41.
8
Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Arch Pathol Lab Med. 2012 Dec;136(12):1533-40. doi: 10.5858/arpa.2011-0609-OA. Epub 2012 Aug 20.
9
HPV: from the cervical smear to the research bench to the court room.
Clin Leadersh Manag Rev. 2003 Nov-Dec;17(6):341-5.
10
Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
Mol Diagn Ther. 2010 Aug 1;14(4):215-22. doi: 10.1007/BF03256376.
Zotero 插件